 SorafenibTM has the potential to inhibit tumor growth, tumor angiogenesis , and enhance radiation response. This study will test the combination of SorafenibTM and radiation therapy with or without temozolomide to determine tolerance of the combined treatments. Defining safe dosing of SorafenibTM in this combination therapy will be achieved. 